Analysis 1.22.

Comparison 1 Anti‐leukaemic therapy plus anti‐CD20 versus anti‐leukaemic therapy alone (anti‐leukaemic therapy identical in both groups), Outcome 22 MRD negativity ‐ subgrouped by different treatment regimens.

Comparison 1 Anti‐leukaemic therapy plus anti‐CD20 versus anti‐leukaemic therapy alone (anti‐leukaemic therapy identical in both groups), Outcome 22 MRD negativity ‐ subgrouped by different treatment regimens.